Alibaba reported its quarterly financial results, which sent the stock price soaring.
1 extracted signal · 1 resolved · 0 still active
Parkev Tatevosian, CFAIndependent analyst profile- Source published
- 02 Sept 2025, 23:22 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC

AI-generated source summary
This is a fundamental analysis of Alibaba's stock. The analyst mentions that Alibaba's stock has been performing well. He points out that AI-related product revenue achieved triple-digit growth for the eighth consecutive quarter. The Cloud Intelligence Group experienced accelerated revenue growth. Management remains committed to investing in consumption and AI plus cloud to capture opportunities and drive long-term growth. Overall revenue increased by 2% year-over-year, or 10% excluding divestitures. The adjusted EBITDA decreased by 14%. He calculates Alibaba's intrinsic value per share to be $158.83, while the current market price is $135. The management team is buying back their stock and are aggressive about this. He is less bullish than before, as the share price has increased, but still thinks the stock is a buy for long-term investors. He will update his recommendation on September 1, 2025.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Parkev Tatevosian, CFA
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
